Requests that the FDA declare that the drug product, Tolmetin Capsules 600 mg is suitable for submission in an Abbreviated New Drug Application.
🏛 Food and Drug Administration (FDA)FDA-2026-P-1833
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Feb 19, 2026No comment period